These data suggest a very complex “nucleic acid battle” in which TRIM33 transcripts may complement with and prevent transcription of several lncRNA genes overexpressed in cancer, which in turn may restrict TRIM33 expression directly or by sequestering TRIM33 mRNA-binding microRNAs, or lead to TRIM33-defective splicing mechanisms. This evidence concerns the gene TRIM33 and cancer.